Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa. 2019

Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
Department of Infectious Diseases, Guy's Hospital, Kings College London, London, United Kingdom.

Serious infections such as endocarditis due to extremely drug-resistance gram-negative bacteria are an increasing challenge. Here, we present successful adjunctive use of cefiderocol for a patient with persistently bacteremic healthcare-associated native aortic valve endocarditis due to an extended-spectrum beta-lactamase-positive Pseudomonas aeruginosa susceptible in vitro only to colistin, following failure of conventional therapeutic options.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D003091 Colistin Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Polymyxin E,Colimycin,Colisticin,Colistin Sulfate,Coly-Mycin,Totazina,Sulfate, Colistin
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097602 Cefiderocol A siderophore cephalosporin with enhanced activity against GRAM-NEGATIVE AEROBIC BACTERIA. Cefiderocol Sulfate Tosylate,Fetroja,S-649266,S 649266,S649266
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
June 2022, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
November 2019, Pharmacotherapy,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
May 1986, The Journal of antimicrobial chemotherapy,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
January 2023, Indian journal of pathology & microbiology,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
July 2023, Antimicrobial agents and chemotherapy,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
January 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
December 2021, JAC-antimicrobial resistance,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
December 1985, Antimicrobial agents and chemotherapy,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
January 2020, IDCases,
Jonathan D Edgeworth, and Domenico Merante, and Sanjay Patel, and Christopher Young, and Paul Jones, and Seema Vithlani, and Duncan Wyncoll, and Peter Roberts, and Andrew Jones, and Tsutae Den Nagata, and Mari Ariyasu, and David M Livermore, and Richard Beale
June 2021, JAC-antimicrobial resistance,
Copied contents to your clipboard!